,FAPI

Vinisha Gunasekaran1, Avanthiga Subrhamanian1, Nivetha Ambalavanan2

  • 1Department of Nuclear Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Clinical nuclear medicine
|January 23, 2025
PubMed
概括

这项研究强调了一种良性乳腺腺瘤病例,该病例在PET/CT扫描上显示了纤维细胞激活蛋白抑制剂 (FAPI) 的高吸收率. 这一发现对于区分良性乳腺疾病与恶性乳腺疾病至关重要,减少了假阳性.